Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment (2018)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/278861
Publication URI: http://dx.doi.org/10.1101/278861
Type: Preprint